Navigation Links
GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA)

ell as improvements in other disease-activity measures.

In the subgroup of patients receiving concomitant stable doses of methotrexate, comprising 178 patients, results across the three dose levels of ofatumumab studied showed that an ACR20 response was obtained by 42% (p=0.006), 56% (p<0.001) and 50% (p=0.001) of patients in the 300 mg, 700 mg and 1000 mg dose groups, respectively compared to 16% in the placebo group. An ACR50 response was obtained by 21%, 26% and 26% of patients receiving the varying doses of ofatumumab, with 8%, 2% and 5% obtaining an ACR70 response. The corresponding responses for the placebo group were 7% and 0%.

At 24 weeks, the patients' immune responses to study medication (ofatumumab or placebo) were also evaluated by testing for the presence of human anti-human antibodies (HAHAs). All patients tested negative at 24 weeks.

Overall, 72% (300 mg p<0.001; 700 mg p=0.001; 1000 mg p=0.001) of patients treated with each of the ofatumumab doses experienced at least a moderate (moderate or good) EULAR response compared to 40% of patients receiving placebo at week 24.

The data also showed that ofatumumab appeared well tolerated, with no increased frequency of serious infections. Approximately half of the adverse events occurred on infusion days (51%) with the most frequently reported being mild or moderate (CTC grade 1-2 events), including throat irritation, dyspnoea and rash.

"These results represent another positive milestone in the development of ofatumumab. They will enable us to progress development in the rheumatoid arthritis (RA) indication and help bring this potentially important treatment to patients suffering from this often painful and debilitating condition," commented Dr. Kathy Rouan, Vice President, Research and Development, GlaxoSmithKline.

"The level of response of patients in the study illustrates the potential of ofatumumab in the treatment of RA and we hope to see similar results in the P
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
2. New Data on Genmab and GlaxoSmithKlines Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
3. Genmabs HuMax-EGFr Shows Broad Potential in Cancer Treatment
4. The Past, Present and Future of HLA Typing
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
10. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
11. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:9/19/2014)... Conn. , Sept. 19, 2014 UBM ... , a leading online community to help oncologists and ... information available regarding the use of targeted therapies and ... cancer research and treatment.  Every September, ... a way to raise awareness about blood cancers—helping to ...
(Date:9/19/2014)... , Sept. 19, 2014  Pressure BioSciences, Inc. ... it has received and approved all parts required ... and has begun to manufacture the new PCT-based ... will be ready for shipment by mid-October and ... released at a rate of about one per ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
... The Hanger Ivan R. Sabel Foundation today announced it ... Grapes for Humanity/US, an internationally recognized charitable foundation that has ... innocent victims of conflict and disease around the world.  The ... Foundation to continue its charitable efforts at its prosthetic clinic ...
... July 12 Ferring Pharmaceuticals Inc., the makers of ... Bat for the Cure charity, in an effort to "strike-out ... the organization,s Minor League Baseball initiative across the country. FIRMAGON® is ... , , ...
Cached Medicine Technology:Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US 2Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 2Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 3Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 4
(Date:9/20/2014)... 2014 Recently, Best Cheap Hosting ... launched its new website. The new site provides ... hosting products for customers. Here, people can find ... purchasing decision. Also, it has recommended some excellent ... One of the great web hosting suppliers, InMotion ...
(Date:9/20/2014)... September 20, 2014 Recently, UWDress.com, an ... and women’s special occasion outfits, has launched a special ... company’s prom outfits are popular among worldwide clients. Now, ... wholesale prom dresses on its website. , ... customers from around the world. Great custom made items ...
(Date:9/20/2014)... September 20, 2014 RBSEO Services, which ... marketing companies, has announced it provides an affordable website ... , This announcement would benefit those new and ... market but cannot afford to pay a big amount ... visibility of their websites in top search results for ...
(Date:9/20/2014)... 2014 “Motherhood is a wonderful gift and ... their latest article , “We know that you want ... that’s what we want to do as well.” , The ... should expect from their Family Physicians who practice obstetrics while ... motherhood. , To learn more about Community Health Center ...
(Date:9/19/2014)... September 20, 2014 Consistent premium ... for the Vision Insurance industry in recent years; ... detriment of industry margins. From 2009 to 2014, ... operators provide coverage for routine eye exams and ... eyeglasses, contact lens and refractive surgery. According to ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4
... 17 In an effort to help,prepare ... Bayer,Corporation and the United Nations Environment Programme,s ... a new World Environment Day,partnership and launched ... schools., The International Children,s Painting Competition ...
... Great ... More Heart Benefits, HORSHAM, Pa., Dec. 17 ... bulge -- from holiday parties and family,feasts, NutriSystem, ... the company,s breakthrough weight-loss, health and,wellness platform., ...
... Media to Educate Consumers on the ... Complexities of ... in,software and services for the healthcare benefits market, today held ... in the Charleston headquarters, the Benefitfocus Media Studio is,the first-of-its ...
... to their GP under a new scheme that has the ... electronic transfer of repeat prescriptions between general practices and pharmacies ... bid to streamline the system and make it faster and ... on prescription errors. , And now the scheme is to ...
... be much tougher than is typically done, study finds , ... small (1 centimeter or less), certain kinds of breast cancer ... researchers say. , A team at the Mayo Clinic in ... (HER2+) and triple negative (HER2- and ER/PR-) tumors that have ...
... (Oakland, Calif.) The Agency for Healthcare Research and ... Health Research for a study that uses electronic medical ... 175,000 adults to find ways to improve the quality ... which will begin to yield findings next summer, will ...
Cached Medicine News:Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 3Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 4Health News:With Calorie Counting on Holiday Hiatus, NutriSystem Offers 'Advanced' Resolution for 2008 2Health News:With Calorie Counting on Holiday Hiatus, NutriSystem Offers 'Advanced' Resolution for 2008 3Health News:With Calorie Counting on Holiday Hiatus, NutriSystem Offers 'Advanced' Resolution for 2008 4Health News:Benefitfocus(R) Unwraps First-of-Its-Kind Healthcare Media Studio 2Health News:Benefitfocus(R) Unwraps First-of-Its-Kind Healthcare Media Studio 3Health News:Prescription for an electronic revolution? 2Health News:Prescription for an electronic revolution? 3Health News:Even Tiny Breast Tumors May Need Aggressive Treatment 2Health News:Agency for Healthcare Research and Quality funds KP study of electronic records for heart disease 2
The UNI_CLIP® is a reliable and stable compression staple....
... Indications include painful arthritic deformity ... in the subtalar joint, failed fusion ... the tibial plafond and/or talus where ... the ankle joint combined with severe ...
... System from DePuy is the first total ... of support that bridges the fused tibiofibular ... distribution. The Agility Ankle, developed in conjunction ... allow for normal alignment during the stance ...
... the key clinical and economic issues of ... is designed to maximize tension control while ... system combines efficient instrumentation with a simple ... system is indicated for general orthopaedic trauma ...
Medicine Products: